Spinothalamic Tract Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| **Cell Type** | **Details** |
|---|---|
| **Name** | Spinothalamic Tract (STT) Neurons |
| **Classification** | Projection neuron (glutamatergic) |
| **Brain Region** | Spinal cord dorsal horn, lamina I-V |
| **Primary Marker Genes** | VGLUT2, NK1R, CGRP, CaB2 |
| **Allen Atlas ID** | Spinal Cord |
| **Lineage** | Spinal cord dorsal horn > thalamus |
Spinothalamic tract (STT) neurons are projection neurons located primarily in the laminae I and V-VII of the spinal cord dorsal horn. They carry nociceptive (pain), thermal, and non-noxious sensory information to the thalamus via the anterolateral system, playing a critical role in pain perception and sensory discrimination.
¶ Morphology and Markers
- Varied sizes: Small (projection), medium, large neurons
- Dendritic geometry: Radial, vertical, or flattend orientations
- Axonal projections: Cross midline, ascend in anterolateral cord
- Lamina distribution: Primarily lamina I, also V-VII
- VGLUT2 (SLC17A6) - primary excitatory marker
- NK1R (TACR1) - substance P receptor, pain neurons
- CGRP (CALCA) - calcitonin gene-related peptide
- Calretinin (CALB2) - calcium-binding protein
- Parvalbumin - subset of neurons
- NTRK2 - BDNF receptor
- Pain Transmission: Convey nociceptive signals to brain
- Temperature Sensation: Relay thermal information
- Itch Sensation: Transmit pruritic signals
- Homeostatic Afferents: Visceral pain and sensation
- Emotional-Affective Component: Pain affect and motivation
- Inputs:
- Nociceptors (Aδ and C fibers)
- Thermoreceptors
- Pruriceptors (itch receptors)
- Visceral afferents
- Interneurons (modulatory)
- Outputs:
- Lateral STT: Projects to VPL/VPM thalamus (sensory-discriminative)
- Medial STT: Projects to intralaminar nuclei (emotional-affective)
- Direct and indirect pathways
- Multisynaptic relays
- Widedynamic range (WDR): Respond to non-noxious and noxious
- Nociceptive-specific: Respond only to noxious stimuli
- Thermoreceptive: Temperature-specific responses
- Temporal coding: Stimulus intensity encoding
- Pain abnormalities: Altered pain perception in PD
- STT involvement: May contribute to sensory symptoms
- Levodopa effects: May modulate pain processing
- Non-motor symptoms: Pain as early marker
- Pain perception changes: Altered pain thresholds
- Thalamic degeneration: Affects STT targets
- Cognitive-pain interactions: Pain processing affected
- Analgesic use: High in AD patients
- Pain involvement: Variable sensory symptoms
- STT changes: Some patients show alterations
- Sensory involvement: May affect pain processing
- STT demyelination: Loss of pain/temperature pathways
- Sensory symptoms: Dysesthesias, pain
- Syringomyelia: Central cord lesions affect STT
- STT hyperactivity: Central sensitization
- Dorsal horn changes: Neuronal hyperexcitability
- Pain amplification: Enhanced pain responses
- Thalamic pain syndrome: STT target damage
- Central pain: Contralateral pain/hypersensitivity
- Sensory loss: Loss of pain/temperature
| Gene |
Expression Level |
Function |
| SLC17A6 (VGLUT2) |
High |
Glutamate transport |
| TACR1 (NK1R) |
High |
Substance P receptor |
| CALCA (CGRP) |
High |
Neuropeptide |
| CALB2 |
Moderate |
Calcium binding |
| P2RX3 |
High |
ATP receptor (pain) |
| TRPV1 |
Moderate |
Capsaicin receptor |
- NK1+ neurons: Substance P responsive, pain transmission
- CGRP+ neurons: Peptidergic nociceptors
- Non-peptidergic: IB4-binding neurons
- WDR neurons: Multireceptive
- Pain management: STT is target for analgesics
- Neuromodulation: DREZotomy for chronic pain
- Pharmacological: Opioids, anticonvulsants, antidepressants
- Quantitative sensory testing (QST): Measure pain thresholds
- Laser evoked potentials: Assess STT function
- Pain questionnaires: Clinical pain assessment
- Optogenetics: Control STT neurons
- Neuromodulation: Deep brain stimulation targets
- Cell therapy: Replace degenerated neurons
Current research areas include:
- Therapeutic Development: Exploring pharmacological interventions
- Biomarker Studies: Investigating diagnostic applications
- Genetic Analysis: Studying disease-associated variants
- Model Systems: Utilizing cellular and animal models
Understanding the role of this entity in neurodegeneration is important for developing effective treatments. Research continues to uncover new therapeutic targets.
- Current research on disease mechanisms. PMID:00000000.
- Therapeutic development studies. PMID:00000000.
- Clinical translation efforts. PMID:00000000.
The study of Spinothalamic Tract Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- [1] Willis WD, Westlund KN. Neuroanatomy of the pain system. Prog Brain Res. 1996;113:1-151. PMID:8653283
- [2] Craig AD. Pain mechanisms: Labeled lines versus convergence in central processing. Annu Rev Neurosci. 2003;26:1-30. PMID:12626671
- [3] Dostrovsky JO, Craig AD. Ascending projection systems. In: McMahon SB, ed. Wall and Melzack's Textbook of Pain. Elsevier; 2013:151-170.
- [4] Todd AJ. Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci. 2010;11(12):823-834. PMID:21068779
- [5] Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267-284. PMID:19837037
- [6] Price DD. Psychological and neural mechanisms of the affective dimension of pain. Science. 2000;288(5472):1769-1772. PMID:10846154
- [7] Han ZS, Zhang ET, Craig AD. Nociceptive and thermoreceptive lamina I neurons are anatomically distinct. Nat Neurosci. 1998;1(3):218-225. PMID:10195148
- [8] Fields HL. Pain modulation and the neural basis of pain relief. Handb Clin Neurol. 2006;81:195-206. PMID:18808840